- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/18 - Erythrocytes
Patent holdings for IPC class A61K 35/18
Total number of patents in this class: 413
10-year publication summary
|
30
|
31
|
46
|
55
|
53
|
47
|
40
|
23
|
28
|
14
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Rubius Therapeutics, Inc. | 65 |
34 |
| Erytech Pharma | 68 |
22 |
| RegenLab USA LLC | 72 |
16 |
| Hemanext Inc. | 85 |
15 |
| The Regents of the University of California | 19839 |
13 |
| Biomet Manufacturing, LLC | 1025 |
12 |
| Biomet, Inc. | 130 |
7 |
| Boston Medical Center Corporation | 113 |
7 |
| ZB Manufacturing, LLC | 119 |
7 |
| Cerus Corporation | 94 |
6 |
| Trustees of Boston University | 973 |
6 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3131 |
6 |
| The General Hospital Corporation | 4710 |
5 |
| Terumo Kabushiki Kaisha | 5506 |
5 |
| ViaCell, LLC | 6 |
5 |
| Whitehead Institute for Biomedical Research | 319 |
5 |
| Sangamo Therapeutics, Inc. | 415 |
5 |
| Beam Therapeutics Inc. | 232 |
5 |
| Westlake Therapeutics (Hangzhou) Co. Limited | 17 |
5 |
| Epicentrx, Inc. | 90 |
4 |
| Other owners | 223 |